NCT02910531 - Lipoic Acid Supplement for Cystine Stone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions

Cystinuria

Interventions

DIETARY_SUPPLEMENT

Alpha lipoic acid

Already mentioned in arm/group descriptions.

DRUG

Placebo

Already mentioned in arm/group descriptions.

Trial Locations (1)

University of California, San Francisco, San Francisco

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Thomas Chi, MD

OTHER